Literature DB >> 28529568

A different representation of natural T cells and natural killer cells between tumor-infiltrating and periphery lymphocytes in human hepatocellular carcinoma.

Xiao-Feng Li1,2,3, Dong Dai1,2,3, Xiu-Yu Song1,2,3, Jian-Jing Liu1,2,3, Lei Zhu1,2,3, Xiang Zhu1,2,3, Wenchao Ma1,2,3, Wengui Xu1,2,3.   

Abstract

Natural T cells [cluster of differentiation (CD) 3+CD56+] and natural killer (NK) cells (CD3-CD56+) are particularly abundant in the human liver and serve an important role in immune responses in the liver. The aim of the present study was to extensively determine the phenotypic and functional characteristics of natural T and NK cells in human hepatocellular carcinoma (HCC). Tumorous and non-tumorous tissue infiltrating lymphocytes (TILs and NILs, respectively) and peripheral blood mononuclear cells (PBMCs) from patients with hepatocellular carcinoma (HCC) were obtained to determine the frequency and phenotype of natural T/NK cells by a multicolor fluorescence activated cell sorting analysis. The abundance of natural T cells and NK cells was decreased in TILs vs. NILs (natural T cells, 6.315±1.002 vs. 17.16±1.804; NK cells, 6.324±1.559 vs. 14.52±2.336, respectively). However such results were not observed in PBMCs from HCC patients vs. that of healthy donors. Notably, a substantial fraction of the natural T cells (21.96±5.283) in TILs acquired forkhead box P3 (FOXP3) expression, and the FOXP3+ natural T cells lost the expression of interferon-γ and perforin. Conversely, being similar to the conventional FOXP3+ regulatory T cells, the FOXP3+ natural T cells assumed a specific phenotype that was characteristic of CD25+, CD45RO+ and cytotoxic T-lymphocyte-associated protein 4+. Consistent with the phenotypic conversion, the present functional results indicate that FOXP3 expression in natural T cells contributes to the acquisition of a potent immunosuppressive capability. In conclusion, the present study describes a different representation of natural T cells and NK cells in local tumor tissues and in the periphery blood of patients with HCC, and identified a new type of FOXP3-expressing natural T cell spontaneously arising in the TILs of HCC.

Entities:  

Keywords:  human hepatocellular carcinoma; natural T cells; natural killer cells; regulatory T cell

Year:  2017        PMID: 28529568      PMCID: PMC5431491          DOI: 10.3892/ol.2017.5808

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  44 in total

1.  Rapamycin combined with TGF-β converts human invariant NKT cells into suppressive Foxp3+ regulatory cells.

Authors:  Lúcia Moreira-Teixeira; Mariana Resende; Odile Devergne; Jean-Philippe Herbeuval; Olivier Hermine; Elke Schneider; Michel Dy; Anabela Cordeiro-da-Silva; Maria C Leite-de-Moraes
Journal:  J Immunol       Date:  2011-12-12       Impact factor: 5.422

2.  Relationship between natural killer activity and development of hepatocellular carcinoma in patients with cirrhosis of the liver.

Authors:  T Nakajima; N Mizushima; K Kanai
Journal:  Jpn J Clin Oncol       Date:  1987-12       Impact factor: 3.019

3.  Hierarchy of alpha fetoprotein (AFP)-specific T cell responses in subjects with AFP-positive hepatocellular cancer.

Authors:  Yang Liu; Sean Daley; Viktoria N Evdokimova; David D Zdobinski; Douglas M Potter; Lisa H Butterfield
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

4.  Possibility of adoptive immunotherapy with peripheral blood-derived CD3⁻CD56+ and CD3+CD56+ cells for inducing antihepatocellular carcinoma and antihepatitis C virus activity.

Authors:  Marlen Doskali; Yuka Tanaka; Masahiro Ohira; Kohei Ishiyama; Hirotaka Tashiro; Kazuaki Chayama; Hideki Ohdan
Journal:  J Immunother       Date:  2011-03       Impact factor: 4.456

5.  Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

Authors:  Qiang Gao; Shuang-Jian Qiu; Jia Fan; Jian Zhou; Xiao-Ying Wang; Yong-Sheng Xiao; Yang Xu; Yi-Wei Li; Zhao-You Tang
Journal:  J Clin Oncol       Date:  2007-06-20       Impact factor: 44.544

6.  Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Valpha24-JalphaQ and gammadelta T cell receptor bearing cells.

Authors:  S Norris; D G Doherty; C Collins; G McEntee; O Traynor; J E Hegarty; C O'Farrelly
Journal:  Hum Immunol       Date:  1999-01       Impact factor: 2.850

7.  Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance.

Authors:  Xuefang Cao; Sheng F Cai; Todd A Fehniger; Jiling Song; Lynne I Collins; David R Piwnica-Worms; Timothy J Ley
Journal:  Immunity       Date:  2007-10-04       Impact factor: 31.745

8.  Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway.

Authors:  Guangyong Peng; Helen Y Wang; Weiyi Peng; Yukiko Kiniwa; Kook Heon Seo; Rong-Fu Wang
Journal:  Immunity       Date:  2007-07-26       Impact factor: 31.745

9.  Functional and genomic analyses of FOXP3-transduced Jurkat-T cells as regulatory T (Treg)-like cells.

Authors:  Joon-Young Kim; Han-Jong Kim; Elaine M Hurt; Xin Chen; O M Zack Howard; William L Farrar
Journal:  Biochem Biophys Res Commun       Date:  2007-08-10       Impact factor: 3.575

10.  Phenotypic and functional changes of cytotoxic CD56pos natural T cells determine outcome of acute hepatitis C virus infection.

Authors:  Lucy Golden-Mason; Nicole Castelblanco; Cliona O'Farrelly; Hugo R Rosen
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

View more
  7 in total

Review 1.  Recent Advances in Molecular Mechanisms of the NKG2D Pathway in Hepatocellular Carcinoma.

Authors:  Jian Wang; Cun-Di Li; Lin Sun
Journal:  Biomolecules       Date:  2020-02-14

2.  Highly differential count of circulating and tumor infiltrating immune cells in patients with non-HCV/non-HBV hepatocellular carcinoma.

Authors:  Markus Bo Schoenberg; Tong Zhu; Jingcheng Hao; Julian Nikolaus Bucher; Xiaokang Li; Xinyu Li; Yongsheng Han; Dionysios Koliogiannis; Michaela Svihla; Markus Otto Guba; Jens Werner; Alexandr V Bazhin
Journal:  Cancer Immunol Immunother       Date:  2021-09-28       Impact factor: 6.630

Review 3.  The Role of Natural Killer T Cells in Cancer-A Phenotypical and Functional Approach.

Authors:  Daniëlle Krijgsman; Marianne Hokland; Peter J K Kuppen
Journal:  Front Immunol       Date:  2018-02-27       Impact factor: 7.561

Review 4.  Innate Immune Cells: A Potential and Promising Cell Population for Treating Osteosarcoma.

Authors:  Zenan Wang; Zhan Wang; Binghao Li; Shengdong Wang; Tao Chen; Zhaoming Ye
Journal:  Front Immunol       Date:  2019-05-16       Impact factor: 7.561

Review 5.  Tertiary Lymphatic Structures in Primary Hepatic Carcinoma: Controversy Cannot Overshadow Hope.

Authors:  Weili Jia; Tianchen Zhang; Qianyun Yao; Jianhui Li; Ye Nie; Xinjun Lei; Zhenzhen Mao; Yanfang Wang; Wen Shi; Wenjie Song
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786

6.  Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.

Authors:  Daniëlle Krijgsman; Natasja L de Vries; Anni Skovbo; Morten N Andersen; Marloes Swets; Esther Bastiaannet; Alexander L Vahrmeijer; Cornelis J H van de Velde; Mirjam H M Heemskerk; Marianne Hokland; Peter J K Kuppen
Journal:  Cancer Immunol Immunother       Date:  2019-05-03       Impact factor: 6.968

7.  Topographical Distribution and Spatial Interactions of Innate and Semi-Innate Immune Cells in Pancreatic and Other Periampullary Adenocarcinoma.

Authors:  Sebastian Lundgren; Patrick Micke; Jacob Elebro; Margareta Heby; Ina Hrynchyk; Björn Nodin; Karin Leandersson; Artur Mezheyeuski; Karin Jirström
Journal:  Front Immunol       Date:  2020-09-10       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.